Assessment of metabolite quantitation reproducibility in serial 3D- 1H-MR spectroscopic imaging of human brain using stereotactic repositioning

Magnetic Resonance in Medicine

Volumn 58, Issue 4, 2007, Pages 666-673

  Langer, Deanna L ^a   Rakaric, Peter ^a   Kirilova, Anna ^a   Jaffray, David A ^a,b   Damyanovich, Andrei Z ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain; Healthy volunteer study; Magnetic resonance spectroscopy; Metabolite analysis; Reproducibility

Indexed keywords

AMINO ACIDS; BIOMOLECULES; BRAIN; CRAMER-RAO BOUNDS; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; MEDIAN FILTERS;

COEFFICIENTS OF VARIATIONS; CRAMER RAO LOWER BOUND; HEALTHY VOLUNTEERS; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; METABOLITE ANALYSIS; MR SPECTROSCOPIC IMAGING; REPRODUCIBILITIES; STATISTICAL FILTERING;

METABOLITES;

CHOLINE; CREATINE; GLUTAMIC ACID; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; FEMALE; HEAD; HUMAN; IMAGE QUALITY; IMAGING SYSTEM; MALE; METABOLITE; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT POSITIONING; PHANTOM; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS; STEREOTAXIC SURGERY; THREE DIMENSIONAL IMAGING;

EID: 35048827082     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21351     Document Type: Article

References (27)

1. Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 2004;17:10-20.
2. Graves EE, Nelson SJ, Vigneron DB, Chin C, Verhey L, McDermott M, Larson D, Sneed PK, Chang S, Prados MD, Lamborn K, Dillon WP. A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 2000;46:319-326; discussion 326-328.
3. Chan AA, Lau A, Pirzkall A, Chang SM, Verhey LJ, Larson D, McDermott MW, Dillon WP, Nelson SJ. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma. J Neurosurg 2004;101:467-475.
4. Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S, McKnight TR. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:20-31.
5. Wald LL, Nelson SJ, Day MR, Noworolski SE, Henry RG, Huhn SL, Chang S, Prados MD, Sneed PK, Larson DA, Wara WM, McDermott M, Dillon WP, Gutin PH, Vigneron DB. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997;87:525-534.
6. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di Chiro G. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516-524.
7. Degaonkar MN, Pomper MG, Barker PB. Quantitative proton magnetic resonance spectroscopic imaging: Regional variations in the corpus callosum and cortical gray matter. J Magn Reson Imaging 2005;22:175-179.
8. Wiedermann D, Schuff N, Matson GB, Soher BJ, Du AT, Maudsley AA, Weiner MW. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability. Magn Reson Imaging 2001;19:1073-1080.
9. Geurts JJ, Barkhof F, Castelijns JA, Uitdehaag BM, Polman CH, Pouwels PJ. Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility. J Magn Reson Imaging 2004;20:366-371.
10. Hammen T, Stadibauer A, Tomandl B, Ganslandt O, Pauli E, Huk W, Neundorfer B, Stefan H. Short TE single-voxel 1H-MR spectroscopy of hippocampal structures in healthy adults at 1.5 Tesla - how reproducible are the results? NMR Biomed 2005;18:195-201.
11. Schirmer T, Auer DP. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 2000;13:28-36.
12. Brooks WM, Friedman SD, Stidley CA. Reproducibility of 1H-MRS in vivo. Magn Reson Med 1999;41:193-197.
13. Marshall I, Wardlaw J, Cannon J, Slattery J, Sellar RJ. Reproducibility of metabolite peak areas in 1H MRS of brain. Magn Reson Imaging 1996;14:281-292.
14. Chard DT, McLean MA, Parker GJ, MacManus DG, Miller DH. Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging 2002;15:219-225.
15. Li BS, Babb JS, Soher BJ, Maudsley AA, Gonen O. Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 2002;47:439-446.
16. Tedeschi G, Bertolino A, Campbell G, Barnett AS, Duyn JH, Jacob PK, Moonen CT, Alger JR, Di Chiro G. Reproducibility of proton MR spectroscopic imaging findings. AJNR Am J Neuroradiol 1996;17:1871-1879.
17. Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, Malaspina D, Gorman JM, Mann JJ, Lamelle M, Kaufmann CA. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies. Psychiatry Res 2000;98:163-175.
18. Charles HC, Lazeyras F, Tupler LA, Krishnan KR. Reproducibility of high spatial resolution proton magnetic resonance spectroscopic imaging in the human brain. Magn Reson Med 1996;35:606-610.
19. Jackson EF, Doyle TJ, Wolinsky JS, Narayana PA. Short TE hydrogen-1 spectroscopic MR imaging of normal human brain: reproducibility studies. J Magn Reson Imaging 1994;4:545-551.
20. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21:1645-1649.
21. Fan G, Sun B, Wu Z, Guo Q, Guo Y. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol 2004;59:77-85.
22. Rijpkema M, Schuuring J, van der Meulen Y, van der Graaf M, Bernsen H, Boerman R, van der Kogel A, Heerschap A. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging. NMR Biomed 2003;16:12-18.
23. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260-264.
24. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
25. Tedeschi G, Bertolino A, Righini A, Campbell G, Raman R, Duyn JH, Moonen CT, Alger JR, Di Chiro G. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 1995;45:1384-1391.
26. Li BS, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 2003;21:923-928.
27. Nelson SJ. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 2001;46:228-239.